The dangers of the “Head Down” position in patients with untreated pituitary macroadenomas: case series and review of literature Satoshi KiyofujiAvital PerryMichael J. Link OriginalPaper 13 December 2017 Pages: 231 - 237
A case series of atypical features of patients with biopsy-proven isolated IgG4-related hypophysitis and normal serum IgG4 levels Kevin C. J. YuenKelley J. MoloneyMarc R. Mayberg OriginalPaper 16 December 2017 Pages: 238 - 246
A prospective longitudinal study of Pasireotide in Nelson’s syndrome Eleni DanielMiguel DebonoJohn Newell-Price OriginalPaper Open access 08 January 2018 Pages: 247 - 255
Pituitary xanthogranulomas: clinical features, radiological appearances and post-operative outcomes R. VedN. LogierC. Hayhurst OriginalPaper Open access 23 January 2018 Pages: 256 - 265
MGMT assessment in pituitary adenomas: comparison of different immunohistochemistry fixation chemicals Alexander S. G. MickoRomana HöftbergerStefan Wolfsberger OriginalPaper Open access 17 January 2018 Pages: 266 - 273
Fall in thyroid stimulating hormone (TSH) may be an early marker of ipilimumab-induced hypophysitis Sunita M. C. De SousaNisa SheriffKatherine T. T. Tonks OriginalPaper 29 January 2018 Pages: 274 - 282
Biochemical efficacy of long-acting lanreotide depot/Autogel in patients with acromegaly naïve to somatostatin-receptor ligands: analysis of three multicenter clinical trials Hussain AlqurainiMaria del Pilar SchneiderAriel Barkan OriginalPaper 22 January 2018 Pages: 283 - 289
Corticotrophic pituitary carcinoma with cervical metastases: case series and literature review Frederick YooEdward C. KuanMarilene B. Wang ReviewPaper 05 February 2018 Pages: 290 - 301
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly Sabrina ChiloiroGherardo MazziottiLaura De Marinis OriginalPaper 03 February 2018 Pages: 302 - 308
Correction to: Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly Sabrina ChiloiroGherardo MazziottiLaura De Marinis Author Correction 23 February 2018 Pages: 309 - 309
How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review Michiel J. van EsdonkEline J. M. van ZutphenJacobus Burggraaf ReviewPaper Open access 31 March 2018 Pages: 310 - 322
Cognitive-behavioral therapy improves the quality of life of patients with acromegaly Lia Silvia KunzlerLuciana Ansaneli NavesLuiz Augusto Casulari ReviewPaper 11 April 2018 Pages: 323 - 333